In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab. [electronic resource]
Producer: 20060525Description: 1337-41 p. digitalISSN:- 0250-7005
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Biotransformation
- Camptothecin -- administration & dosage
- Cetuximab
- Colorectal Neoplasms -- blood
- Cross-Over Studies
- Drug Interactions
- Female
- Glucuronides -- blood
- Humans
- Irinotecan
- Male
- Middle Aged
- Prodrugs -- administration & dosage
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.